about
Pharmacological treatment for muscle weakness and wasting in myotonic dystrophyDrug treatment for myotoniaTherapeutics development in myotonic dystrophy type 1.Pentamidine rescues contractility and rhythmicity in a Drosophila model of myotonic dystrophy heart dysfunction.Lower limb muscle impairment in myotonic dystrophy type 1: the need for better guidelines.Myotonic Dystrophy Type 1 Management and Therapeutics.Treating pediatric neuromuscular disorders: The future is now.
P2860
Q24240183-B413B818-6289-4662-A365-01B53A798F24Q24244905-26236294-F157-4A6D-8A3E-589B81588DEEQ30425796-0E4263DE-43FE-4EA2-9EAA-6DE619BFF199Q36506541-CCDC0F5D-A456-474F-AB8E-FB26E99DBAD7Q38268524-C4037A66-4AD5-4ACD-91EE-4B6B983E6DA8Q39003493-A321DB5A-5656-4DE3-9BAF-3C5A94793B2FQ52756417-6811E06D-79D4-4BE3-AF27-E8D7D29BE3A7
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Dehydroepiandrosterone for myotonic dystrophy type 1.
@en
type
label
Dehydroepiandrosterone for myotonic dystrophy type 1.
@en
prefLabel
Dehydroepiandrosterone for myotonic dystrophy type 1.
@en
P2093
P50
P1433
P1476
Dehydroepiandrosterone for myotonic dystrophy type 1
@en
P2093
A Vershueren
C Desnuelle
D Orlikowski
E Lagrange
P304
P356
10.1212/01.WNL.0000324257.35759.40
P407
P577
2008-08-01T00:00:00Z